FDANonrulemakingFDA-2026-N-3499
Who commented on this docket
Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments
4 organizations filed 4 public comments on Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments, at the Food and Drug Administration. The comment window closed 82d ago.
Organizations
4
Comments
4
RIN
—
Comment window
closed 82d ago
Commenters (4)
- American Academy of Pediatrics (AAP)1 filing · confidence 97%
- Obesity Action Coalitiontrade assoc.1 filing · confidence 85%
- Pfizer Inc.unverified attribution1 filing · confidence 70%
- The Obesity Societytrade assoc.1 filing · confidence 85%
Attribution is name-based and imperfect. regulations.gov data is public record.